Alector (ALEC) Shares Outstanding (Weighted Average) (2018 - 2026)

Alector (ALEC) reported Shares Outstanding (Weighted Average) of $110.6 million for Q1 2026, up 11.26% year-over-year from $99.4 million in Q1 2025, and up 7.37% quarter-over-quarter from $103.0 million in Q4 2025.

Alector (ALEC) Shares Outstanding (Weighted Average) (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Shares Outstanding (Weighted Average) data on file, last reported at $110.6 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $110.6 million, up 11.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $110.6 million (up 11.26% YoY), and the FY2025 annual result was $103.0 million, up 6.64% from the prior year.
  • Shares Outstanding (Weighted Average) climbed to $110.6 million in Q1 2026 per ALEC's latest filing, from $103.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $110.6 million in Q1 2026 and troughed at $82.1 million in Q1 2022.
  • A 5-year average of $92.0 million and a median of $93.8 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) advanced 1.1% in 2023, then advanced 16.77% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $82.5 million in 2022, then advanced by 1.54% to $83.7 million in 2023, then increased by 15.35% to $96.6 million in 2024, then grew by 6.64% to $103.0 million in 2025, then grew by 7.37% to $110.6 million in 2026.
  • Business Quant data shows ALEC's Shares Outstanding (Weighted Average) at $110.6 million in Q1 2026, $103.0 million in Q4 2025, and $102.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Alector 193.53 Mn -12.98 Mn - 110.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 110.59 Mn
Dec 31, 2025 103.00 Mn
Sep 30, 2025 102.60 Mn
Jun 30, 2025 100.37 Mn
Mar 31, 2025 99.40 Mn
Dec 31, 2024 96.59 Mn
Sep 30, 2024 97.52 Mn
Jun 30, 2024 96.67 Mn
Mar 31, 2024 93.81 Mn
Dec 31, 2023 83.73 Mn
Sep 30, 2023 83.51 Mn
Jun 30, 2023 83.19 Mn
Mar 31, 2023 83.10 Mn
Dec 31, 2022 82.47 Mn
Sep 30, 2022 82.60 Mn
Jun 30, 2022 82.25 Mn
Mar 31, 2022 82.10 Mn
Dec 31, 2021 80.42 Mn
Sep 30, 2021 80.05 Mn
Jun 30, 2021 79.60 Mn